Search results
Goldman Sachs raises Royalty Pharma stock target on deal activity By Investing.com
Investing.com· 21 hours agoOn Friday, Goldman Sachs (NYSE:GS) updated its financial model for Royalty Pharma (NASDAQ:RPRX),...
Goldman Sachs (GS) Ascends But Remains Behind Market: Some Facts to Note
Zacks via Yahoo Finance· 3 days agoThe investment community will be paying close attention to the earnings performance of Goldman Sachs...
Bata India's Q4 Performance: A Mixed Bag with Promising Strategies By Investing.com
Investing.com· 3 days agoIn its latest quarterly report, Bata India (NS:BATA) delivered a mixed performance that was slightly...
Goldman Sachs cuts Maxeon Solar stock to sell, slashes target By Investing.com
Investing.com· 4 days agoThe decision follows Maxeon's recent financial disclosures. Maxeon reported its fourth quarter of...
Goldman's 10 industry themes for 2024 - Part 1 By Investing.com
Investing.com· 4 days agoThe quarterly earnings season has largely ended, and Goldman Sachs has taken this opportunity to...
U.S. Services PMI Returns to Expansion Path in May: 5 Picks
Zacks via Yahoo Finance· 22 hours agoWingstop has an expected revenue and earnings growth rate of 27.5% and 36.7%, respectively, for the...
Goldman Sachs updates US Conviction List for June By Investing.com
Investing.com· 4 days agoGoldman Sachs updates US Conviction List for June
Goldman thinks this solar stock has more to run after an 80% rally in 2 months
CNBC· 5 days agoWith tailwinds from tariffs and data center demand on the horizon, First Solar still has substantial...
NVIDIA stock retains Conviction Buy rating from Goldman By Investing.com
Investing.com· 5 days agoOn Monday, Goldman Sachs (NYSE:GS) maintained its Conviction Buy rating and a $1,200.00 price target...
Zacks Research Equities Analysts Lift Earnings Estimates for Magnolia Oil & Gas Co. (NYSE:MGY)
ETF DAILY NEWS· 5 days agoResearch analyst N. Choudhury now expects that the company will earn $0.56 per share for the quarter, up from their previous forecast of $0.52. The consensus estimate for ...